Galectin Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Galectin therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Galectin Therapeutics Today - Breaking & Trending Today

Galectin Therapeutics (NASDAQ:GALT) Cut to Sell at StockNews.com

Galectin Therapeutics (NASDAQ:GALT – Get Free Report) was downgraded by StockNews.com from a “hold” rating to a “sell” rating in a research report issued on Wednesday. Separately, HC Wainwright reissued a “buy” rating and set a $11.00 price target on shares of Galectin Therapeutics in a report on Tuesday, April 9th. Check Out Our Latest […] ....

Jamesc Czirr , Vanguard Group Inc , Wealth Ltd , Wealthspire Advisors , Galectin Therapeutics Inc , Beacon Capital Management , Securities Exchange Commission , Retirement Guys Formula , Galectin Therapeutics , Get Free Report , Therapeutics Trading Down , Exchange Commission , Guys Formula , Capital Management , Therapeutics Inc , Galectin Therapeutics Daily ,

Galectin Therapeutics (NASDAQ:GALT) Rating Increased to Hold at StockNews.com

StockNews.com upgraded shares of Galectin Therapeutics (NASDAQ:GALT – Free Report) from a sell rating to a hold rating in a report published on Tuesday. Separately, HC Wainwright reissued a buy rating and set a $11.00 target price on shares of Galectin Therapeutics in a research note on Tuesday, April 9th. Get Our Latest Stock Analysis […] ....

Jamesc Czirr , Retirement Guys Formula , Galectin Therapeutics Company Profile , Galectin Therapeutics Inc , Wealth Ltd , Wealthspire Advisors , Beacon Capital Management , A Davidson , Da Davidson , Galectin Therapeutics , Free Report , Get Free Report , Guys Formula , Capital Management , Therapeutics Inc , Galectin Therapeutics Daily ,

Galectin Therapeutics (NASDAQ:GALT) Upgraded at StockNews.com

StockNews.com upgraded shares of Galectin Therapeutics (NASDAQ:GALT – Free Report) from a sell rating to a hold rating in a report released on Tuesday morning. Separately, HC Wainwright restated a buy rating and set a $11.00 price objective on shares of Galectin Therapeutics in a report on Tuesday, April 9th. View Our Latest Report on […] ....

Jamesc Czirr , Retirement Guys Formula , Galectin Therapeutics Inc , Vanguard Group Inc , Wealthspire Advisors , Wealth Ltd , Beacon Capital Management , Securities Exchange Commission , Galectin Therapeutics , Free Report , Get Free Report , Exchange Commission , Guys Formula , Capital Management , Therapeutics Inc , Galectin Therapeutics Daily ,

Galectin Therapeutics (NASDAQ:GALT) Downgraded by StockNews.com

Galectin Therapeutics (NASDAQ:GALT) Downgraded by StockNews.com
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Jamesc Czirr , Vanguard Group Inc , Galectin Therapeutics Inc , A Davidson , Wealthspire Advisors , Wealth Ltd , Retirement Guys Formula , Galectin Therapeutics , Free Report , Get Free Report , Guys Formula , Therapeutics Inc , Galectin Therapeutics Daily ,

GALT Stock Earnings: Galectin Therapeutics Misses EPS for Q1 2024

GALT Stock Earnings: Galectin Therapeutics Misses EPS for Q1 2024
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

Galectin Therapeutics , Place Earnings ,